ANI PHARMACEUTICALS, INC.
ANIP US00182C1036
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 52% | -15% | 38% | -3% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Davis Krista VP |
98.04 USD |
1,000 Sold |
98,040 USD |
19/09/2025 | 19/09/2025 |
| Cook Meredith VP |
98.42 USD |
400 Sold |
39,368 USD |
12/09/2025 | 12/09/2025 |
| Pera Antonio R O |
94.94 USD |
7,292 Sold |
692,302 USD |
03/09/2025 | 03/09/2025 |
| Leonard Matthew J |
90.62 USD |
2,528 Sold |
229,087 USD |
25/08/2025 | 25/08/2025 |
| Davis Krista SR VP |
91.10 USD |
1,763 Sold |
160,609 USD |
22/08/2025 | 22/08/2025 |
| Shanmugam Muthusamy SR OFF |
90.44 USD |
52,988 Sold |
4,792,235 USD |
20/08/2025 | 21/08/2025 |
| Pera Antonio R O |
89.73 USD |
5,421 Sold |
486,426 USD |
20/08/2025 | 20/08/2025 |
| Shanmugam Muthusamy SR OFF |
90.27 USD |
47,012 Sold |
4,243,773 USD |
20/08/2025 | 20/08/2025 |
| Thoma Jeanne O |
89.76 USD |
6,865 Sold |
616,202 USD |
18/08/2025 | 18/08/2025 |
| Thoma Jeanne O |
88.87 USD |
14,675 Sold |
1,304,167 USD |
18/08/2025 | 18/08/2025 |